Kaiqiang Li

668 total citations
51 papers, 492 citations indexed

About

Kaiqiang Li is a scholar working on Molecular Biology, Biomaterials and Immunology. According to data from OpenAlex, Kaiqiang Li has authored 51 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Biomaterials and 9 papers in Immunology. Recurrent topics in Kaiqiang Li's work include Nanoplatforms for cancer theranostics (6 papers), Phytochemistry and Bioactive Compounds (6 papers) and Extracellular vesicles in disease (5 papers). Kaiqiang Li is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), Phytochemistry and Bioactive Compounds (6 papers) and Extracellular vesicles in disease (5 papers). Kaiqiang Li collaborates with scholars based in China, United States and Australia. Kaiqiang Li's co-authors include Ke Hao, Zhen Wang, Junjie Deng, Lingling Wu, Jianxin Lyu, Zhen Wang, Wei Yang, Kaixuan Li, Wanli Jiang and Bingyu Chen and has published in prestigious journals such as The Science of The Total Environment, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Kaiqiang Li

45 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaiqiang Li China 11 241 104 101 99 76 51 492
Wenjing Lai China 13 296 1.2× 69 0.7× 57 0.6× 95 1.0× 144 1.9× 36 583
Afshin Nikkhoo Iran 9 230 1.0× 68 0.7× 46 0.5× 61 0.6× 80 1.1× 9 411
Hui Tan China 15 199 0.8× 59 0.6× 76 0.8× 140 1.4× 91 1.2× 30 534
Zhuomao Mo China 14 209 0.9× 60 0.6× 98 1.0× 107 1.1× 68 0.9× 27 552
Xiongjie Zhu China 13 321 1.3× 67 0.6× 67 0.7× 63 0.6× 42 0.6× 23 537
Peng Hua China 16 322 1.3× 42 0.4× 68 0.7× 95 1.0× 54 0.7× 34 617
Dianbao Zhang China 16 323 1.3× 77 0.7× 39 0.4× 71 0.7× 60 0.8× 54 636
Simon Heine Germany 9 223 0.9× 72 0.7× 44 0.4× 117 1.2× 30 0.4× 13 513

Countries citing papers authored by Kaiqiang Li

Since Specialization
Citations

This map shows the geographic impact of Kaiqiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaiqiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaiqiang Li more than expected).

Fields of papers citing papers by Kaiqiang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaiqiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaiqiang Li. The network helps show where Kaiqiang Li may publish in the future.

Co-authorship network of co-authors of Kaiqiang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Kaiqiang Li. A scholar is included among the top collaborators of Kaiqiang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaiqiang Li. Kaiqiang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Bo, et al.. (2025). Decoding the Implications of Zinc in the Development and Therapy of Leukemia. Advanced Science. 12(9). e2412225–e2412225. 3 indexed citations
2.
Xu, Wei, et al.. (2025). Polarity protein Par6: Unraveling its mechanisms in tumor development and research advances. Cellular Signalling. 136. 112181–112181.
4.
Li, Kaiqiang, et al.. (2025). RNA methyltransferase METTL16: From molecular mechanisms to therapeutic prospects in cancers. Cancer Letters. 624. 217698–217698. 3 indexed citations
5.
Zhang, Yifang, Kaiqiang Li, Qiuping Wu, et al.. (2025). Neutrophil-to-albumin ratio: a novel predictor of osteoporosis in rheumatoid arthritis. Frontiers in Immunology. 16. 1666884–1666884.
6.
Luo, Xuling, Yaling Wang, Xiaoting Zhang, et al.. (2024). β-Mangostin targets and suppresses glioma via STING activation and tumor-associated microglia polarization. Biomedicine & Pharmacotherapy. 177. 117074–117074. 3 indexed citations
8.
Li, Kaiqiang, et al.. (2024). Application of Nanoparticles for Immunotherapy of Allergic Rhinitis. International Journal of Nanomedicine. Volume 19. 12015–12037. 2 indexed citations
9.
Xia, Tian, Yuting Zhu, Kaiqiang Li, et al.. (2024). Microneedles loaded with cerium-manganese oxide nanoparticles for targeting macrophages in the treatment of rheumatoid arthritis. Journal of Nanobiotechnology. 22(1). 103–103. 28 indexed citations
10.
Wang, Hongqin, et al.. (2024). Black Phosphorus Nanosheets-Loaded Single-Atom Gold Nanoenzymes for Enhanced Photodynamic Therapy of Hepatocellular Carcinoma. International Journal of Nanomedicine. Volume 19. 12583–12592. 2 indexed citations
11.
Zhu, Bo, Zhonghua Li, Kaiqiang Li, et al.. (2024). Zinc as a potential regulator of the BCR-ABL oncogene in chronic myelocytic leukemia cells. Journal of Trace Elements in Medicine and Biology. 83. 127407–127407. 2 indexed citations
12.
Li, Qin, Lingling Wu, Yimin Yang, et al.. (2023). Functional targeted therapy for glioma based on platelet membrane-coated nanogels. Cancer Nanotechnology. 14(1). 13 indexed citations
13.
Wang, Jian, et al.. (2023). Dual Responsive Magnetic Drug Delivery Nanomicelles with Tumor Targeting for Enhanced Cancer Chemo/Magnetothermal Synergistic Therapy. International Journal of Nanomedicine. Volume 18. 7647–7660. 7 indexed citations
14.
Chen, Junfa, Jing Jin, Kaiqiang Li, et al.. (2022). Progresses and Prospects of Neuroprotective Agents-Loaded Nanoparticles and Biomimetic Material in Ischemic Stroke. Frontiers in Cellular Neuroscience. 16. 868323–868323. 20 indexed citations
15.
Wang, Xueli, Yimin Yang, Junjie Deng, et al.. (2022). PARP inhibitors diminish DNA damage repair for the enhancement of tumor photodynamic therapy. Photodiagnosis and Photodynamic Therapy. 40. 103058–103058. 3 indexed citations
16.
Zhou, Ying, Kaiqiang Li, Yaoqiang Du, et al.. (2021). Protein interacting with C-kinase 1 is involved in epithelial-mesenchymal transformation and suppresses progress of gastric cancer. Medical Oncology. 38(4). 34–34. 8 indexed citations
17.
Li, Kaiqiang, Lingling Wu, Yili Chen, et al.. (2020). <p>Cytotoxic and Antiproliferative Effects of β-Mangostin on Rat C6 Glioma Cells Depend on Oxidative Stress Induction via PI3K/AKT/mTOR Pathway Inhibition</p>. Drug Design Development and Therapy. Volume 14. 5315–5324. 20 indexed citations
18.
Wang, Zhen, You‐Min Ying, Kaiqiang Li, et al.. (2017). Marsdeniae tenacissima extract-induced growth inhibition and apoptosis in hepatoma carcinoma cells is mediated through the p53/nuclear factor-κB signaling pathway. Experimental and Therapeutic Medicine. 14(3). 2477–2484. 3 indexed citations
19.
Yu, Zhang, Zhen Wang, Ting Jin, et al.. (2017). Hyperechoic demarcation line between a tumor and the muscularis propria layer as a marker for deciding the endoscopic treatment of gastric submucosal tumor. Journal of Zhejiang University SCIENCE B. 18(8). 707–716. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026